Esculapsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-04-02
Share capital
250,000.00 PLN
Registered address
Wallenroda 2E, 20-607 Lublin, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 53 days late).

  • 202502/07/2026
  • 202427/06/2025
  • 202301/07/2024
  • 202211/07/2023
  • 202106/09/2022
  • 202030/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 39%
Division · Retail trade2,701 / 9,915
Top 27%
City · Lublin507 / 4,864
Top 10%
Voivodeship · Lubelskie1,376 / 10,228
Top 13%
Country · Poland42,686 / 297,932
Top 14%

Results vs industry

Revenue
This companyUSD 3.50mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 30.73kMedianUSD 20.70kAverageUSD 86.94k
Operating costs
This companyUSD 3.42mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 633.63kMedianUSD 543.65kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Esculap has been an NFZ healthcare provider since 2008. In 2026 it is performing 4 contracts with a total value of USD 567.26. All its contracts were worth USD 7.79k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmeslubelskie2USD 567.26
Provision of medical deviceslubelskie1USD 0.00
Other services provided in pharmacieslubelskie1USD 0.00

Authorized Representatives

Katarzyna Anna Gargol – Attorney-in-fact
Janina Marianna Hyz – President of the Management Board

Manner of representation

Authorized to submit declarations of will and sign on behalf of the company are: in the case of a one-person management board, the company is represented by the President of the Management Board; in the case of a multi-member management board, joint action by two members of the management board or by a member of the management board jointly with a commercial proxy is required.

Ownership

OwnerSharesShare valueStake
Ryszard Zbigniew Gargolage 71
300$40,518.6460%
Wojciech Bartłomiej Gargolage 44
200$27,012.4340%

Ryszard Zbigniew Gargol and Wojciech Bartłomiej Gargol hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2004-05-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $113,393.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$5,423
De minimis aid (in accordance with Commission Regulation 2023/2831)
$3,566
De minimis aid (in accordance with Commission Regulation 2023/2831)
$41

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Fragalsp. z o.o.
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Vitasp. z o.o.

Change history

DateEvent
2020-12-03Switch to PKD 2007
2012-03-07Share capital increase
2004-04-02Entered in the register

FAQ

Last updated: 2026-10-07